BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2130995)

  • 1. A study of the effect of introducing a restrictive cervical screening policy on laboratory workload and cervical cancer detection rates.
    Channer JL; Mackenzie EF
    Cytopathology; 1990; 1(1):13-7. PubMed ID: 2130995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six years' audit of laboratory workload and rates of referral for colposcopy in a cervical screening programme in three districts.
    Raffle AE; Alden B; Mackenzie EF
    BMJ; 1990 Oct; 301(6757):907-11. PubMed ID: 2261537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical screening in women over the age of 50: results of a population-based multicentre study.
    Flannelly G; Monaghan J; Cruickshank M; Duncan I; Johnson J; Jordan J; Campbell M; Patnick J
    BJOG; 2004 Apr; 111(4):362-8. PubMed ID: 15008774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The agreement between self-reported cervical smear abnormalities and screening programme records.
    Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
    J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four and a half year follow up of women with dyskaryotic cervical smears.
    Fletcher A; Metaxas N; Grubb C; Chamberlain J
    BMJ; 1990 Sep; 301(6753):641-4. PubMed ID: 2224218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision analysis for best management of mildly dyskaryotic smear.
    Johnson N; Sutton J; Thornton JG; Lilford RJ; Johnson VA; Peel KR
    Lancet; 1993 Jul; 342(8863):91-6. PubMed ID: 8100917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study.
    Blanks RG; Moss SM; Coleman DA; Swerdlow AJ
    BJOG; 2007 Nov; 114(11):1408-13. PubMed ID: 17803716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preparation of additional smears from a cervical scrape: impact on the rate of detection of cervical neoplasia.
    Al-Awadhi R; Byrne M; Coleman DV
    Cytopathology; 2001 Jun; 12(3):151-6. PubMed ID: 11380556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-based cytology and conventional smears compared over two 12-month periods.
    Williams AR
    Cytopathology; 2006 Apr; 17(2):82-5. PubMed ID: 16548992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nonscreening smears on screening smear results: a statistical analysis with its implications for the NHS cervical screening programme.
    Rice S; Slater DN; Hewer EM
    Cytopathology; 2000 Jun; 11(3):158-65. PubMed ID: 10877275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of age stratification for colposcopy referral following initial diagnosis of mild dyskaryosis.
    Crowther S; Turner L; Magee D; Gibbons D
    J Clin Pathol; 2008 May; 61(5):665-8. PubMed ID: 18227138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid rescreening of cervical smears as a quality control method.
    Cross PA
    Cytopathology; 1997 Apr; 8(2):79-84. PubMed ID: 9134332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. PRISMATIC Project Management Team.
    Lancet; 1999 Apr; 353(9162):1381-5. PubMed ID: 10227217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of high grade dyskaryotic cervical smears likely to be missed on rapid rescreening.
    O'Sullivan JP; Chapman PA; Jenkins L; Smith R
    Acta Cytol; 2000; 44(1):37-40. PubMed ID: 10667157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy.
    Cooper P; Kirby AJ; Spiegelhalter DJ; Whitehead AL; Patterson A
    Cytopathology; 1992; 3(6):331-9. PubMed ID: 1486177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of women with mild and moderate cervical dyskaryosis.
    Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
    BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cervical cancer with the human papillomavirus test in an area of central Italy with no previous active cytological screening programme.
    Confortini M; Giorgi Rossi P; Barbarino P; Passarelli AM; Orzella L; Tufi MC
    J Med Screen; 2010; 17(2):79-86. PubMed ID: 20660436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications.
    Coleman DV; Poznansky JJ
    Cytopathology; 2006 Jun; 17(3):127-36. PubMed ID: 16719855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.